Funder
Silab R&D
French Ministry of Research
Subject
Drug Discovery,Pharmacology
Reference60 articles.
1. Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
2. Cytokines, chemokines, and other biomarkers of response for checkpoint inhibitor therapy in skin cancer;Bridge;Front Med.,2018
3. Targeted localized use of therapeutic antibodies: A review of non-systemic, topical and oral applications;Jones;Crit. Rev. Biotechnol.,2016
4. Antibody fragments;Nelson;MAbs,2010
5. Emerging landscape in psoriasis management: from topical application to targeting biomolecules;Rapalli;Biomed. Pharmacother.,2018
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献